Literature DB >> 26604077

Lack of endogenous cholecystokinin promotes cholelithogenesis in mice.

H H Wang1,2, M Liu3, P Portincasa4, P Tso3, D Q-H Wang1,2.   

Abstract

BACKGROUND: Celiac disease is an autoimmune enteropathy caused by a permanent intolerance to dietary gluten in genetically predisposed individuals. Cholecystokinin (CCK) release from the proximal small intestine and gallbladder emptying in response to a fatty meal are greatly reduced in celiac patients before they start the gluten-free diet, showing a genetic predisposition to gallstones.
METHODS: To elucidate the complex pathophysiological mechanisms determining the biliary characteristic of celiac disease, we investigated the effect of the absence of endogenous CCK on cholesterol crystallization and gallstone formation in mice fed a lithogenic diet for 28 days. KEY
RESULTS: Fasting gallbladder volumes were increased and the response of gallbladder emptying to the high-fat diet was impaired in CCK knockout (KO) mice compared to wild-type mice. Because of the absence of CCK, small intestinal transit time was prolonged and intestinal cholesterol absorption was increased. During 28 days of feeding, elevated biliary cholesterol concentrations and gallbladder stasis promoted the growth and agglomeration of solid cholesterol crystals into microlithiasis and stones. Thus, cholesterol crystallization and gallstone formation were accelerated in CCK KO mice. In contrast, daily intraperitoneal administration of CCK-8 reduced gallstone formation in CCK KO mice even on the lithogenic diet. CONCLUSIONS & INFERENCES: The lack of endogenous CCK enhances susceptibility to gallstones by impairing gallbladder contractile function and small intestinal motility function. These findings show that celiac disease is an important risk factor for gallstone formation and the gallbladder motility function should be routinely examined by ultrasonography and gallbladder stasis should be prevented in celiac patients.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  bile salt; celiac disease; cholesterol absorption; cholesterol crystallization; gallbladder motility; lithogenic bile

Mesh:

Substances:

Year:  2015        PMID: 26604077      PMCID: PMC4760924          DOI: 10.1111/nmo.12734

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  44 in total

Review 1.  Celiac sprue.

Authors:  Richard J Farrell; Ciarán P Kelly
Journal:  N Engl J Med       Date:  2002-01-17       Impact factor: 91.245

2.  Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile.

Authors:  D Q Wang; B Paigen; M C Carey
Journal:  J Lipid Res       Date:  1997-07       Impact factor: 5.922

3.  Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing systems.

Authors:  D Q Wang; M C Carey
Journal:  J Lipid Res       Date:  1996-03       Impact factor: 5.922

Review 4.  Biliary dyskinesia: role of the sphincter of Oddi, gallbladder and cholecystokinin.

Authors:  S Krishnamurthy; G T Krishnamurthy
Journal:  J Nucl Med       Date:  1997-11       Impact factor: 10.057

5.  Pancreatic function in CCK-deficient mice: adaptation to dietary protein does not require CCK.

Authors:  K A Lacourse; L J Swanberg; P J Gillespie; J F Rehfeld; T L Saunders; L C Samuelson
Journal:  Am J Physiol       Date:  1999-05

6.  Phenotypic characterization of lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice. Pathophysiology Of biliary lipid secretion.

Authors:  D Q Wang; F Lammert; B Paigen; M C Carey
Journal:  J Lipid Res       Date:  1999-11       Impact factor: 5.922

7.  Gallbladder emptying and somatostatin and cholecystokinin plasma levels in celiac disease.

Authors:  M Fraquelli; M T Bardella; M Peracchi; B M Cesana; P A Bianchi; D Conte
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

Review 8.  Dietary guidelines and implementation for celiac disease.

Authors:  Cynthia Kupper
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

9.  Overexpression of estrogen receptor alpha increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice.

Authors:  Helen H Wang; Nezam H Afdhal; David Q-H Wang
Journal:  J Lipid Res       Date:  2005-12-27       Impact factor: 5.922

Review 10.  Cholecystokinin cells.

Authors:  R A Liddle
Journal:  Annu Rev Physiol       Date:  1997       Impact factor: 19.318

View more
  10 in total

1.  Cd36 knockout mice are protected against lithogenic diet-induced gallstones.

Authors:  Yan Xie; Vincenza Cifarelli; Terri Pietka; Elizabeth P Newberry; Susan M Kennedy; Amin Khalifeh-Soltani; Robin Clugston; Kamran Atabai; Nada A Abumrad; Nicholas O Davidson
Journal:  J Lipid Res       Date:  2017-06-20       Impact factor: 5.922

Review 2.  Impaired intestinal cholecystokinin secretion, a fascinating but overlooked link between coeliac disease and cholesterol gallstone disease.

Authors:  Helen H Wang; Min Liu; Xiaodan Li; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2017-03-08       Impact factor: 4.686

Review 3.  Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

Review 4.  An update on the pathogenesis of cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q-H Wang; Piero Portincasa
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

Review 5.  Mouse models of gallstone disease.

Authors:  Tony Y Wang; Piero Portincasa; Min Liu; Patrick Tso; David Q-H Wang
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

Review 6.  Obesity and Gallstones.

Authors:  Nela Melissa Parra-Landazury; Jacqueline Cordova-Gallardo; Nahum Méndez-Sánchez
Journal:  Visc Med       Date:  2021-04-23

Review 7.  An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13.

Authors:  Helen H Wang; Piero Portincasa; Min Liu; Patrick Tso; David Q-H Wang
Journal:  Genes (Basel)       Date:  2020-11-29       Impact factor: 4.096

Review 8.  Recent advances in neuropeptide-related omics and gene editing: Spotlight on NPY and somatostatin and their roles in growth and food intake of fish.

Authors:  Xiaozheng Yu; Haijun Yan; Wensheng Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-10-04       Impact factor: 6.055

Review 9.  Research progress on the immune microenvironment of the gallbladder in patients with cholesterol gallstones.

Authors:  Jing-Yi Jiao; Xiao-Jun Zhu; Chun Zhou; Peng Wang
Journal:  World J Gastrointest Surg       Date:  2022-09-27

Review 10.  Recent advances in understanding and managing cholesterol gallstones.

Authors:  Agostino Di Ciaula; Piero Portincasa
Journal:  F1000Res       Date:  2018-09-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.